Evaluation of NSCLC Cytology Cell Block Specimens Using Ventana PD-L1 SP263 Immunohistochemistry Assay

被引:0
|
作者
Chauhan, Aastha [1 ]
Racila, Emilian [2 ]
Stewart, Jimmie [3 ]
Amin, Khalid [3 ]
机构
[1] Univ Minnesota, St Paul, MN 55108 USA
[2] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Minneapolis, MN USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
335
引用
收藏
页数:2
相关论文
共 50 条
  • [31] PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens
    Banach, Bridget
    Antic, Tatjana
    Mueller, Jeffrey
    LABORATORY INVESTIGATION, 2018, 98 : 133 - 133
  • [32] PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens
    Banach, Bridget
    Antic, Tatjana
    Mueller, Jeffrey
    MODERN PATHOLOGY, 2018, 31 : 133 - 133
  • [33] Concordance of tumor cell (TC) and immune cell (IC) staining with Ventana SP142, Ventana SP263, Dako 28-8 and Dako 22C3 PD-L1 IHC tests in NSCLC patient samples.
    Scott, Marietta L.
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Barker, Craig
    Scorer, Paul
    Rebelatto, Marlon
    Al-Masri, Hytham
    Walker, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
    Marchetti, Antonio
    Barberis, Massimo
    Franco, Renato
    De Luca, Graziano
    Pace, Maria Vittoria
    Staibano, Stefania
    Volante, Marco
    Buttitta, Fiamma
    Guerini-Rocco, Elena
    Righi, Luisella
    D'antuono, Tommaso
    Scagliotti, Giorgio V.
    Pinto, Carmine
    De Rosa, Gaetano
    Papotti, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : 1654 - 1663
  • [35] PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Using Sp142, Sp263 and E1L3N
    Brunelli, Matteo
    Calio', Anna
    Munari, Enrico
    Pedron, Serena
    Ciocchetta, Elisa
    Bogina, Giuseppe
    Zamboni, Giuseppe
    Martignoni, Guido
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 862 - 862
  • [36] A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockade
    Cortellini, Alessio
    Zampacorta, Claudia
    De Tursi, Michele
    Grillo, Lucia R.
    Ricciardi, Serena
    Bria, Emilio
    Martini, Maurizio
    Giusti, Raffaele
    Filetti, Marco
    Dal Mas, Antonella
    Russano, Marco
    Dall'Olio, Filippo Gustavo
    Buttitta, Fiamma
    Marchetti, Antonio
    PATHOLOGICA, 2024, 116 (04) : 222 - 231
  • [37] PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Using Sp142, Sp263 and E1L3N
    Brunelli, Matteo
    Calio, Anna
    Munari, Enrico
    Pedron, Serena
    Ciocchetta, Elisa
    Bogina, Giuseppe
    Zamboni, Giuseppe
    Martignoni, Guido
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 862 - 862
  • [38] Assessment of concordance among 22C3, SP263, and SP142 immunohistochemistry assay for PD-L1 expression in non-small cell lung cancer.
    Jung, Chi Young
    Kim, Eun Jin
    Sung, Woo Jung
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 41 - 42
  • [39] New Approach in the Interpretation of Complex Triple-negative Breast Cancer Immunohistochemistry Specimens Processed With VENTANA PD-L1 (SP142) Assay
    Peg, Vicente
    Abengozar-Muela, Marta
    Acosta, Jesus
    Andres, Leire
    Garcia-Rojo, Marcial
    Hardisson, David
    Nicolau, Maria Jesus
    Ramos-Oliver, Irma
    Rodrigo, Maximiliano
    Sanchez-Bernal, Maria Luisa
    Sanz, Julian
    Garrote, Leia
    Ramirez, Ignacio
    Rojo, Federico
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2025, 33 (01) : 15 - 21
  • [40] Expression of PD-L1 on Routine Non-Small Cell Lung Carcinoma Sections: Comparative Assessment of SP263 (Ventana) and 22C3 (DAKO pharmDx)
    Quinn, A. M.
    Gosney, J.
    Bishop, P.
    Bloor, R.
    Harreld, C.
    Mcnulty, C.
    Bowden, R.
    Moss, A.
    Forrest, S.
    Montero, A.
    Chaturvedi, A.
    Joseph, L.
    Paiva-Correia, A.
    Doran, H.
    Taniere, P.
    Crosbie, P.
    Blackhall, F.
    Summers, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S761 - S763